Development of a Versatile and Modular Linker for Antibody-drug Conjugates Based on Oligonucleotide Strand Pairing.

Linker design is crucial to the success of antibody-drug conjugates (ADCs). In this work, we developed a modular link-er format for attaching molecular cargos to antibodies based on strand pairing between complementary oligonucleo-tides. We prepared antibody-oligonucleotide conjugates (AOCs) by attaching 18-mer oligonucleotides to an anti-HER2 antibody through thiol-maleimide chemistry, a method generally applicable to any immunoglobulin with interchain disulfide bridges. The hybridization of drug-bearing complementary oligonucleotides to our AOCs was rapid, stoichi-ometric, and sequence-specific. AOCs loaded with cytotoxic payloads were able to selectively target HER2-overexpressing cell lines such as SK-BR-3 and N87, with in vitro potencies similar to that of the marketed ADC Kadcyla (T-DM1). Our results demonstrated the potential of utilizing AOCs as a highly flexible and modular platform, where a panel of well-characterized AOCs bearing DNA, RNA, or various nucleic acid analogs, such as peptide nucleic acids, could be easily paired with any cargo of choice for a wide range of diagnostic or therapeutic applications.

[1]  I. Sassoon,et al.  Advances in Antibody–Drug Conjugate Design: Current Clinical Landscape and Future Innovations , 2020, SLAS discovery : advancing life sciences R & D.

[2]  A. Wagner,et al.  Antibody-Oligonucleotide Conjugates as Therapeutic, Imaging, and Detection Agents. , 2019, Bioconjugate chemistry.

[3]  A. Yang,et al.  Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models , 2018, mAbs.

[4]  N. Dalchau,et al.  Predicting DNA Hybridization Kinetics from Sequence , 2017, bioRxiv.

[5]  C. Dumontet,et al.  Strategies and challenges for the next generation of antibody–drug conjugates , 2017, Nature Reviews Drug Discovery.

[6]  Z. An,et al.  Antibody-drug conjugates: recent advances in conjugation and linker chemistries , 2016, Protein & Cell.

[7]  N. Hubner,et al.  A covalent and cleavable antibody-DNA conjugation strategy for sensitive protein detection via immuno-PCR , 2016, Scientific Reports.

[8]  Antoine Maruani,et al.  Recent advances in the construction of antibody-drug conjugates. , 2016, Nature chemistry.

[9]  Ying Sun,et al.  Discovery of Pyrophosphate Diesters as Tunable, Soluble, and Bioorthogonal Linkers for Site-Specific Antibody-Drug Conjugates. , 2016, Journal of the American Chemical Society.

[10]  Xiaohui Wang,et al.  Simple Method To Prepare Oligonucleotide-Conjugated Antibodies and Its Application in Multiplex Protein Detection in Single Cells. , 2016, Bioconjugate chemistry.

[11]  B. Tomczuk,et al.  Current ADC Linker Chemistry , 2015, Pharmaceutical Research.

[12]  Anja van Brabant Smith,et al.  Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB–siRNA conjugates , 2014, Nucleic acids research.

[13]  Y. Zu,et al.  Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy , 2014, Molecular therapy. Nucleic acids.

[14]  J. Chin,et al.  Bioorthogonal reactions for labeling proteins. , 2014, ACS chemical biology.

[15]  L. Tchistiakova,et al.  Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates , 2013, mAbs.

[16]  Peter Kuhn,et al.  Site-specific DNA-antibody conjugates for specific and sensitive immuno-PCR , 2012, Proceedings of the National Academy of Sciences.

[17]  Rajeeva Singh,et al.  Synthesis and evaluation of hydrophilic linkers for antibody-maytansinoid conjugates. , 2011, Journal of medicinal chemistry.

[18]  S. Baker,et al.  A preclinical 188Re tumor therapeutic investigation using MORF/cMORF pretargeting and an antiTAG-72 antibody CC49 , 2010, Cancer biology & therapy.

[19]  J. Cooper,et al.  Actin dynamics and endocytosis in yeast and mammals. , 2010, Current opinion in biotechnology.

[20]  Y. Okahata,et al.  Kinetic measurements of DNA hybridization on an oligonucleotide-immobilized 27-MHz quartz crystal microbalance. , 1998, Analytical chemistry.

[21]  G. Veeneman,et al.  Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancer. , 1995, Bioconjugate chemistry.

[22]  G. M. Iverson,et al.  Conjugates of double-stranded oligonucleotides with poly(ethylene glycol) and keyhole limpet hemocyanin: a model for treating systemic lupus erythematosus. , 1994, Bioconjugate chemistry.

[23]  C R Cantor,et al.  Immuno-PCR: very sensitive antigen detection by means of specific antibody-DNA conjugates. , 1992, Science.

[24]  R. Juliano,et al.  Cellular uptake and intracellular fate of antisense oligonucleotides. , 1992, Trends in cell biology.

[25]  L. Neckers,et al.  Characterization of oligonucleotide transport into living cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.